Vice President, Health Economics and Outcomes Research
Crinetics Pharmaceuticals
About this role
The Vice President of Health Economics and Outcomes Research (HEOR) and Real World Evidence (RWE) at Crinetics will lead the company’s global evidence strategy to demonstrate the value of therapies for rare endocrine diseases. Reporting to the SVP of Medical Affairs, the role oversees RWE generation and HEOR direction that supports market access, reimbursement, and lifecycle evidence across commercial and clinical development.
Skills
Qualifications
About Crinetics Pharmaceuticals
crinetics.comCrinetics is here for endocrine disease patients who are eager to find therapies that provide effective disease control and more simplicity in their lives.
Recent company news
Yahoo FinanceCrinetics Pharmaceuticals Highlights Early PALSONIFY Sales, EU Milestone, and GPCR Pipeline at TD Cowen Conf.
3 days ago
MarketBeatWINTON GROUP Ltd Takes Position in Crinetics Pharmaceuticals, Inc. $CRNX
1 day ago
Naître et grandirWill Crinetics Pharmaceuticals Inc. stock attract more institutional investors - Insider Buying & High Win Rate Trade Alerts
4 days ago
SahmWhy Crinetics Pharmaceuticals (CRNX) Is Down 7.1% After Deeper 2025 Loss And New US$207 Million Shelf Registration
1 week ago
Quiver QuantitativeCrinetics Pharmaceuticals Reports $5.4 Million in Q4 2025 Net Revenue from PALSONIFY™ and Plans for Phase 2/3 Study of Atumelnant in 2026
2 weeks ago
About Crinetics Pharmaceuticals
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Crinetics Pharmaceuticals.
Salary
$350k – $390k
per year
More jobs at Crinetics Pharmaceuticals
Similar Jobs
Senior Director, Health Economics & Outcomes Research
Ipsen
Director, Field Health Economics & Outcomes Research (HEOR)
Nuvalent, Inc.
Director, Global Health Economic & Outcomes Research / Real World Evidence (HEOR/RWE lead – BTK Degrader)
BeOne Medicines
Center for Outcomes Research, Real World Evidence and Epidemiology (CORE) Intern
Genmab
Associate Director/ Director, Health Economics and Outcomes Research (HEOR) (Early Stage Pipeline)
ISI1000ISIS
Associate VP - Health Economics and Outcomes Research (HEOR) - Global CMH
Eli Lilly and Company